{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T07:40:22Z","timestamp":1723621222972},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00393-020-00875-3","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T13:03:52Z","timestamp":1600693432000},"page":"855-864","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Wichtigste Impfungen bei Patienten mit rheumatologischen Erkrankungen und warum","Most important vaccinations in patients with rheumatological diseases and why"],"prefix":"10.1007","volume":"79","author":[{"given":"C.","family":"Kneitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"875_CR1","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/annrheumdis-2013-204427","volume":"74","author":"CO Bingham","year":"2015","unstructured":"Bingham\u00a0CO, Rizzo\u00a0W, Kivitz\u00a0A et\u00a0al (2015) Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a\u00a0randomised controlled trial (VISARA). Ann Rheum Dis 74:818\u2013822","journal-title":"Ann Rheum Dis"},{"key":"875_CR2","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","volume":"372","author":"MJM Bonten","year":"2015","unstructured":"Bonten\u00a0MJM, Huijts\u00a0SM, Bolkenbaas\u00a0M et\u00a0al (2015) Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N\u00a0Engl J Med 372:1114\u20131125","journal-title":"N Engl J Med"},{"key":"875_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson\u00a0M, Kim\u00a0JJ, Canfell\u00a0K et al (2020) Impact of HPV vaccination and cervical screening on cervical cancer elimination: a\u00a0comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 395:575\u2013590","journal-title":"Lancet"},{"key":"875_CR4","first-page":"1439","volume":"57","author":"G Chehab","year":"2018","unstructured":"Chehab\u00a0G, Rkichter\u00a0J, Brinks\u00a0R et al (2018) Vaccination coverage in systemic lupus erythematosus\u2014a cross-sectional analysis of the German long-term study (LuLa cohort). Baillieres Clin Rheumatol 57:1439\u20131447","journal-title":"Baillieres Clin Rheumatol"},{"key":"875_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013265","author":"S Cooper","year":"2019","unstructured":"Cooper\u00a0S, Schmidt\u00a0B\u2011M, Zondani Sambala\u00a0E, Swartz\u00a0A, Colvin\u00a0CJ, Leon\u00a0N, Betsch\u00a0C, Charles\u00a0S (2019) Wiysonge Factors that influence parents\u2019 and informal caregivers\u2019 acceptance of routine childhood vaccination: a\u00a0qualitative evidence synthesis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013265","journal-title":"Cochrane Database Syst Rev"},{"key":"875_CR6","doi-asserted-by":"crossref","unstructured":"Epidemiologisches Bulletin 34\/2019","DOI":"10.11621\/vsp.2019.01.34"},{"issue":"6","key":"875_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s00296-011-1808-z","volume":"32","author":"M Feuchtenberger","year":"2012","unstructured":"Feuchtenberger\u00a0M, Kleinert\u00a0S, Schwab\u00a0S, Roll\u00a0P, Scharbatke\u00a0EC, Ostermeier\u00a0E, Voll\u00a0RE, Sch\u00e4fer\u00a0A, Tony\u00a0HP (2012) Vaccination survey in patients with rheumatoid arthritis: a\u00a0cross-sectional study. Rheumatol Int 32(6):1533\u20131539","journal-title":"Rheumatol Int"},{"key":"875_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-21588","author":"V Furer","year":"2019","unstructured":"Furer\u00a0V, Rondaan\u00a0C, Heijstek\u00a0M et\u00a0al (2019) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2019-21588","journal-title":"Ann Rheum Dis"},{"key":"875_CR9","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.vaccine.2015.01.065","volume":"33","author":"I Hmamouchi","year":"2015","unstructured":"Hmamouchi\u00a0I, Winthrop\u00a0K, Launay\u00a0O, Dougados\u00a0M (2015) Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. Vaccine 33:1446\u20131452","journal-title":"Vaccine"},{"key":"875_CR10","first-page":"1294","volume":"248","author":"A Holvast","year":"2009","unstructured":"Holvast\u00a0A, van Assen\u00a0S, de Haan\u00a0A et\u00a0al (2009) Effect of a\u00a0second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Baillieres Clin Rheumatol 248:1294\u20131299","journal-title":"Baillieres Clin Rheumatol"},{"key":"875_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.vaccine.2015.12.029","volume":"34","author":"KB Hertzell","year":"2016","unstructured":"Hertzell\u00a0KB, Pauksens\u00a0K, Rombo\u00a0L et al (2016) Tick-Borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: a\u00a0prospective, open-label, multi-centre study. Vaccine 34:650\u2013655","journal-title":"Vaccine"},{"key":"875_CR12","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1080\/03007995.2017.1329140","volume":"33","author":"Y Huang","year":"2017","unstructured":"Huang\u00a0Y, Wang\u00a0H, Tam\u00a0WWS (2017) Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis. Curr Med Res Opin 33:1901\u20131908","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"875_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/RHU.0000000000000877","volume":"25","author":"S Intongkam","year":"2019","unstructured":"Intongkam\u00a0S, Samakarnthai\u00a0P, Pakchotanon\u00a0R et al (2019) Efficacy and, safety of hepatitis B vaccination in rheumatoid arthritis patients receiving disease-modifying antirheumatic drugs and\/or biologics therapy. J\u00a0Clin Rheumatol 25(8):329\u2013334","journal-title":"J Clin Rheumatol"},{"key":"875_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13075-016-1207-7","volume":"19","author":"Y Izumi","year":"2017","unstructured":"Izumi\u00a0Y, Akazawa\u00a0M, Akeda\u00a0Y et al (2017) The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a\u00a0double-blinded, randomized, placebo-controlled trial. Arthritis Res Ther 19:15","journal-title":"Arthritis Res Ther"},{"key":"875_CR15","first-page":"272","volume":"34","author":"JL Kaine","year":"2007","unstructured":"Kaine\u00a0JL, Kivitz\u00a0AJ, Birbara\u00a0C, Luo\u00a0AY (2007) Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J\u00a0Rheumatol 34:272\u2013279","journal-title":"J Rheumatol"},{"key":"875_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/03009742.2013.788733","volume":"42","author":"T Kobashigawa","year":"2013","unstructured":"Kobashigawa\u00a0T, Nakajima\u00a0A, Taniguchi\u00a0A et\u00a0al (2013) Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a\u00a0large observational cohort. Scand J Rheumatol 42:445\u2013450","journal-title":"Scand J Rheumatol"},{"issue":"48","key":"875_CR17","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","volume":"26","author":"NP Lindsey","year":"2008","unstructured":"Lindsey\u00a0NP, Schroeder\u00a0BA, Miller\u00a0ER et\u00a0al (2008) Adverse event reports following yellow fever vaccination. Vaccine 26(48):6077\u20136082","journal-title":"Vaccine"},{"key":"875_CR18","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1016\/j.vaccine.2018.04.056","volume":"36","author":"CC Mok","year":"2018","unstructured":"Mok\u00a0CC, Ho\u00a0LY, To\u00a0CH (2018) Long-Term immunogenicity of a\u00a0quadrivalent human papillomavirus vaccine in systemic lupus erythematosus. Vaccine 36:3301\u20133307","journal-title":"Vaccine"},{"issue":"6","key":"875_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00103-017-2555-4","volume":"60","author":"T Niehues","year":"2017","unstructured":"Niehues\u00a0T, Bogdan\u00a0C, Hecht\u00a0J, Mertens\u00a0T, Wiese-Posselt\u00a0M, Zepp\u00a0F (2017) Impfen bei Immundefizienz. Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen (I) Grundlagenpapier. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60(6):674\u2013684","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"875_CR20","first-page":"898","volume":"277","author":"JK Park","year":"2018","unstructured":"Park\u00a0JK, Lee\u00a0YJ, Shin\u00a0K et\u00a0al (2018) Impact of temporary methotrexate discontinuation for 2\u00a0weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a\u00a0randomised clinical trial. Ann Rheum Dis 277:898\u2013904","journal-title":"Ann Rheum Dis"},{"key":"875_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0174-9","author":"O Pleguezuelos","year":"2020","unstructured":"Pleguezuelos\u00a0O, James\u00a0E et al (2020) Efficacy of FLU\u2011v, a\u00a0broad-spectrum influenza vaccine, in a\u00a0randomized phase IIb human influenza challenge study. Vaccines. https:\/\/doi.org\/10.1038\/s41541-020-0174-9","journal-title":"Vaccines"},{"key":"875_CR22","first-page":"1664","volume":"55","author":"M Puges","year":"2016","unstructured":"Puges\u00a0M, Biscay\u00a0P, Barnetche\u00a0T et al (2016) Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a\u00a0systematic literature review and meta-analysis. Baillieres Clin Rheumatol 55:1664\u20131672","journal-title":"Baillieres Clin Rheumatol"},{"key":"875_CR23","doi-asserted-by":"publisher","first-page":"e001035","DOI":"10.1136\/rmdopen-2019-001035","volume":"5","author":"C Rondaan","year":"2019","unstructured":"Rondaan\u00a0C, Furer\u00a0V, Heijstek\u00a0MW et\u00a0al (2019) Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a\u00a0systematic literature review for the 2019 update of EULAR recommendations. RMD Open 5:e1035","journal-title":"RMD Open"},{"key":"875_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tmaid.2017.12.004","volume":"21","author":"A Rosdahl","year":"2018","unstructured":"Rosdahl\u00a0A, Herzog\u00a0C, Frisner\u00a0G et al (2018) An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression\u2014A prospective, open-label, multi-center study. Travel Med Infect Dis 21:43\u201350","journal-title":"Travel Med Infect Dis"},{"issue":"23\u201324","key":"875_CR25","first-page":"413","volume":"116","author":"K Schulte","year":"2019","unstructured":"Schulte\u00a0K, Schierke\u00a0H, Tamayo\u00a0M et\u00a0al (2019) Strategien f\u00fcr eine bessere Influenzaimpfquote bei chronisch nierenerkrankten Patienten Dt. \u00c4rzteblatt 116(23\u201324):413","journal-title":"\u00c4rzteblatt"},{"issue":"13\u201314","key":"875_CR26","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0264-410X(02)00041-5","volume":"20","author":"T Vu","year":"2002","unstructured":"Vu\u00a0T, Farish\u00a0S, Jenkins\u00a0M, Kelly\u00a0H (2002) A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over\u00a0 living in the community. Vaccine 20(13\u201314):1831\u20131836","journal-title":"Vaccine"},{"key":"875_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-019-02905-1","author":"N Wagner","year":"2019","unstructured":"Wagner\u00a0N et\u00a0al (2019) Impfen bei Immundefizienz. Bundesgesundheitsblatt. https:\/\/doi.org\/10.1007\/s00103-019-02905-1","journal-title":"Bundesgesundheitsblatt"},{"key":"875_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/art.39482","volume":"68","author":"UA Walker","year":"2016","unstructured":"Walker\u00a0UA, Hoffman\u00a0HM, Williams\u00a0R et al (2016) Brief report. Severe inflammation following vaccination against streptococcus pneumoniae in patients with cryopyrin-associate syndromes. Arthritis Rheumatol 68:516\u2013520","journal-title":"Arthritis Rheumatol"},{"key":"875_CR29","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1016\/j.vaccine.2009.07.082","volume":"27","author":"A Whittembury","year":"2009","unstructured":"Whittembury\u00a0A, Ramirez\u00a0G, Hernandez\u00a0H et\u00a0al (2009) Viscerotropic disease following yellow fever vaccination in Peru. Vaccine 27:5974\u20135981","journal-title":"Vaccine"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00875-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-020-00875-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00875-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T07:18:19Z","timestamp":1723619899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-020-00875-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00875-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"17 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Kneitz: Vortragshonorare von GSK, Pfizer, Sanofi. U.\u00a0M\u00fcller-Ladner gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}